Track JFL Life Sciences Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 4.53 %
Low
13.1
High
14.4
1 Month returns: 30.66 %
Low
10.0
High
14.4
1 Year returns: 1.82 %
Low
8.6
High
14.7
3 Year CAGR: -5.76 %
Low
8.6
High
35.5
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for JFL Life Sciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
JFL Life Sciences Ltd. Shareholding Pattern
Quarterly breakdown of JFL Life Sciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in JFL Life Sciences Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of JFL Life Sciences Ltd.?
The current share price of JFL Life Sciences Ltd. is ₹ 13.85 as of 10 Aug 2026.
What is the market capitalisation of JFL Life Sciences Ltd.?
The market capitalisation of JFL Life Sciences Ltd. stands at ₹ 91.40 Cr.
What is the PE ratio of JFL Life Sciences Ltd.?
The Price-to-Earnings (PE) ratio of JFL Life Sciences Ltd. is 14.28 as of the latest trailing twelve months data.
What is the ROE and ROCE of JFL Life Sciences Ltd.?
JFL Life Sciences Ltd. has a Return on Equity (ROE) of 15.00% and a Return on Capital Employed (ROCE) of 18.08% as per the latest financial reports.
What is the 52-week high and low of JFL Life Sciences Ltd.?
The 52-week high of JFL Life Sciences Ltd. is - and the 52-week low is -.
What is the dividend yield of JFL Life Sciences Ltd.?
The dividend yield of JFL Life Sciences Ltd. is 0.57% based on the current market price.
What is the FII and DII holding in JFL Life Sciences Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 31.27% of JFL Life Sciences Ltd. shares.
What sector does JFL Life Sciences Ltd. belong to?
JFL Life Sciences Ltd. operates in the Healthcare sector.
What is the beta of JFL Life Sciences Ltd.?
The beta of JFL Life Sciences Ltd. is 0.49, indicating its price volatility relative to the broader market.
What is the RSI of JFL Life Sciences Ltd.?
The 14-day Relative Strength Index (RSI) of JFL Life Sciences Ltd. is 71.17, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
No corporate action data available.
Stock Analysis
Fundamental analysis overview of JFL Life Sciences Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
PE TTM of 14.28 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -52.86%
What is P/E Ratio?
Median: 30.29
Value 14.28
0.33265.68
Negative
Low dividend yield
The company has a low dividend yield of 0.57%
What is Dividend yield?
Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0725323.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Sep 2022
Dec 2022
Mar 2023
Sep 2023
Mar 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
Indian Promoter
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
67.47
Foreign Promoter
0.00
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.00
-
-
-
0.00
0.00
-
0.00
0.00
0.00
0.00
0.00
Mutual Funds / UTI
0.00
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
0.00
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
32.53
32.53
32.54
32.53
32.53
32.53
32.53
32.53
32.53
32.53
32.53
32.53
Bodies Corporate
4.24
2.33
2.02
1.87
2.22
0.56
0.62
0.40
0.35
0.88
1.24
1.26
Others (incl. Retail)
No. of shareholders
28.29
952
30.20
894
30.52
849
30.66
812
30.31
803
31.97
946
31.91
977
32.13
989
32.18
981
31.65
969
31.29
949
31.27
921
Name
Date
Type
Price
Qty.
Value
NATHABHAI BHIKHABHAI PATEL HUF
25 Sep 2024
buy
₹ 24.50
60.00 k
₹ 14.70 lac
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED
24 Sep 2024
buy
₹ 23.35
96.00 k
₹ 22.42 lac
PRATIK RAJENDRA GANDHI
24 Sep 2024
sell
₹ 23.35
96.00 k
₹ 22.42 lac
PRATIK RAJENDRABHAI GANDHI
24 Sep 2024
sell
₹ 23.35
96.00 k
₹ 22.42 lac
AMRITA JAIN
05 Jul 2024
buy
₹ 58.21
60.00 k
₹ 34.93 lac
AMRITA JAIN
05 Jul 2024
sell
₹ 57.85
40.00 k
₹ 23.14 lac
MITTAL RIMPY
24 Jul 2023
buy
₹ 51.76
72.00 k
₹ 37.27 lac
MITTAL RIMPY
24 Jul 2023
sell
₹ 51.93
64.00 k
₹ 33.24 lac
MITTAL RIMPY
21 Jul 2023
buy
₹ 49.26
76.00 k
₹ 37.44 lac
MITTAL RIMPY
21 Jul 2023
sell
₹ 49.88
76.00 k
₹ 37.91 lac
13.850.2 (1.47%)
1.82% in past 1 year
Company Profile
Overview of JFL Life Sciences Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
JFL Life Sciences Limited is an India-based pharmaceutical company. The Companys business segment comprises manufacturing and selling of pharmaceutical products. It is engaged in domestic as well as international business. The Companys main product categories include Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet, and capsules (General) and Oral Rehydration Solutions (ORS). Its beta-lactam dry powder injection products include Ampicillin Injection, Cefotaxime Sodium Injection, Cefazoline Sodium Injection, meropenem injection, amoxicillin injection, cefTAZidime injection, flucloxacillin injection, among others. Its beta-lactam tablets and capsule products include Cefadroxil Tablets, Cefadroxil Capsules, among others. Its general tablet and capsule products include Azithromycin Tablets, Iburofen Tablets, Ciprofloxacin Tablets, Ofloxacin Tablets, Paracetamol Tablets, among others. These products are offered in different milligrams (mg).
JFL Life Sciences Limited is an India-based pharmaceutical company. The Companys business segment comprises manufacturing and selling of pharmaceutical products. It is engaged in domestic as well as international business. The Companys main product categories include Dry powder injections, Tablets &...